Eterna Therapeutics
ERNA
11 hedge funds and large institutions have $566K invested in Eterna Therapeutics in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
518% more capital invested
Capital invested by funds: $91.7K → $566K (+$474K)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
22% more funds holding
Funds holding: 9 → 11 (+2)
0.24% more ownership
Funds ownership: 0.03% → 0.27% (+0.24%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Corient Private Wealth
Miami,
Florida
|
+$667K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$48.9K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.7K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.21K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$595 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.01K |
| 2 |
Morgan Stanley
New York
|
-$753 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Corient Private Wealth
Miami,
Florida
| $480K | +$667K | +16,823 | +2,400% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $33.8K | +$48.9K | +1,234 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $22.4K | +$595 | +15 | +2% |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $12.2K | +$17.7K | +446 | New |
|
|
SCA
5
Sippican Capital Advisors
Boston,
Massachusetts
| $10.9K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $5.67K | +$8.21K | +207 | New |
|
7
BlackRock
New York
| $898 | – | – | – |
|
8
AssetMark Inc
Concord,
California
| $146 | – | – | – |
|
|
EWA
9
EverSource Wealth Advisors
Birmingham,
Alabama
| $127 | – | – | – |
|
|
10
Morgan Stanley
New York
| $84 | -$753 | -19 | -86% |
|
11
Bank of America
Charlotte,
North Carolina
| $36 | – | – | – |
|
12
BNP Paribas Financial Markets
Paris,
France
| $11 | – | – | – |
|
|
MA
13
Montag & Associates
Atlanta,
Georgia
| $9 | – | – | – |
|
|
AWM
14
Activest Wealth Management
Aventure,
Florida
| $3 | – | – | – |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$1.01K | -22 | Closed |
|
ERNA Hedge Fund Activity: Q3 2025 in Review
11 of the 7,629 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q3 2025, worth a combined $566K — up 518% from $91.7K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ERNA positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Corient Private Wealth, adding an estimated $667K. The largest seller was UBS Group, exiting entirely with an estimated $1.01K sold.
- 11 institutional investors held Eterna Therapeutics (ERNA) as of Q3 2025, up from 9 in Q2 2025.
- Funds reported $566K of Eterna Therapeutics stock for Q3 2025, up 518% quarter-over-quarter.
- 3 funds opened new Eterna Therapeutics positions in Q3 2025 and 1 closed out, a net change of +2 holders.
- The largest Eterna Therapeutics buyer in Q3 2025 was Corient Private Wealth, an estimated $667K added.
- The largest Eterna Therapeutics seller in Q3 2025 was UBS Group, an estimated $1.01K sold.
Based on aggregated 13F filings for Q3 2025.